Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunological Differences in Influenza and Herpes Zoster Vaccination
NCT05082688Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2021
- Primary completion
- May 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Zoster vaccine recombinant, Fluarix Quadrivalent in herpes zoster (HZ), influenza, sponsored by Radboud University Medical Center. Started Sep 2021; status: completed.
02
Drugs
Zoster vaccine recombinantFluarix Quadrivalent
03
Conditions
herpes zoster (HZ)influenza
Beyond the preview
Go deeper on NCT05082688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05082688.